Your browser doesn't support javascript.
loading
Dynamics of Urinary Calprotectin after Renal Ischaemia.
Ebbing, Jan; Seibert, Felix S; Pagonas, Nikolaos; Bauer, Frederic; Miller, Kurt; Kempkensteffen, Carsten; Günzel, Karsten; Bachmann, Alexander; Seifert, Hans H; Rentsch, Cyrill A; Ardelt, Peter; Wetterauer, Christian; Amico, Patrizia; Babel, Nina; Westhoff, Timm H.
Afiliación
  • Ebbing J; University Hospital Basel, Department of Urology, Basel, Switzerland.
  • Seibert FS; Charité - University Hospital, Campus Benjamin Franklin, Department of Urology, Berlin, Germany.
  • Pagonas N; University Hospital Marien Hospital Herne, Medical Department I, Ruhr University of Bochum, Bochum, Germany.
  • Bauer F; University Hospital Marien Hospital Herne, Medical Department I, Ruhr University of Bochum, Bochum, Germany.
  • Miller K; University Hospital Marien Hospital Herne, Medical Department I, Ruhr University of Bochum, Bochum, Germany.
  • Kempkensteffen C; Charité - University Hospital, Campus Benjamin Franklin, Department of Urology, Berlin, Germany.
  • Günzel K; Charité - University Hospital, Campus Benjamin Franklin, Department of Urology, Berlin, Germany.
  • Bachmann A; Charité - University Hospital, Campus Benjamin Franklin, Department of Urology, Berlin, Germany.
  • Seifert HH; University Hospital Basel, Department of Urology, Basel, Switzerland.
  • Rentsch CA; University Hospital Basel, Department of Urology, Basel, Switzerland.
  • Ardelt P; University Hospital Basel, Department of Urology, Basel, Switzerland.
  • Wetterauer C; University Hospital Basel, Department of Urology, Basel, Switzerland.
  • Amico P; University Hospital Basel, Department of Urology, Basel, Switzerland.
  • Babel N; University Hospital Basel, Department of Nephrology, Basel, Switzerland.
  • Westhoff TH; University Hospital Marien Hospital Herne, Medical Department I, Ruhr University of Bochum, Bochum, Germany.
PLoS One ; 11(1): e0146395, 2016.
Article en En | MEDLINE | ID: mdl-26745147
BACKGROUND: Urinary calprotectin has been identified as a promising biomarker for acute kidney injury. To date, however, the time-dependent changes of this parameter during acute kidney injury remain elusive. The aim of the present work was to define the time-course of urinary calprotectin secretion after ischaemia/reperfusion-induced kidney injury in comparison to neutrophil gelatinase-associated lipocalin, thereby monitoring the extent of tubular damage in nephron sparing surgery for kidney tumours. METHODS: The study population consisted of 42 patients. Thirty-two patients underwent either open or endoscopic nephron sparing surgery for kidney tumours. During the surgery, the renal arterial pedicle was clamped with a median ischaemic time of 13 minutes (interquartile range, 4.5-20.3 minutes) in 26 patients. Ten retro-peritoneoscopic living donor nephrectomy patients and 6 nephron sparing surgery patients in whom the renal artery was not clamped served as controls. Urinary calprotectin and neutrophil gelatinase-associated lipocalin concentrations were repeatedly measured by enzyme-linked immunosorbent assay and assessed according to renal function parameters. RESULTS: Urinary concentrations of calprotectin and neutrophil gelatinase-associated lipocalin increased significantly after ischaemia/reperfusion injury, whereas concentrations remained unchanged after nephron sparing surgery without ischaemia/reperfusion injury and after kidney donation. Calprotectin and neutrophil gelatinase-associated lipocalin levels were significantly increased 2 and 8 hours, respectively, post-ischaemia. Both proteins reached maximal concentrations after 48 hours, followed by a subsequent persistent decrease. Maximal neutrophil gelatinase-associated lipocalin and calprotectin concentrations were 9-fold and 69-fold higher than their respective baseline values. The glomerular filtration rate was only transiently impaired at the first post-operative day after ischaemia/reperfusion injury (p = 0.049). CONCLUSION: Calprotectin and neutrophil gelatinase-associated lipocalin can be used to monitor clinical and sub-clinical tubular damage after nephron sparing surgery for kidney tumours. Urinary calprotectin concentrations start rising within 2 hours after ischaemia/reperfusion-induced kidney injury.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Fase Aguda / Carcinoma de Células Renales / Daño por Reperfusión / Proteínas Proto-Oncogénicas / Trasplante de Riñón / Complejo de Antígeno L1 de Leucocito / Lipocalinas / Neoplasias Renales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Fase Aguda / Carcinoma de Células Renales / Daño por Reperfusión / Proteínas Proto-Oncogénicas / Trasplante de Riñón / Complejo de Antígeno L1 de Leucocito / Lipocalinas / Neoplasias Renales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos